Department of Pathology, Universiti Kebangsaan Malaysia Medical Centre, Cheras, Kuala Lumpur, Malaysia.
Cancer Epidemiol. 2010 Aug;34(4):442-7. doi: 10.1016/j.canep.2010.04.010. Epub 2010 May 6.
The incidence of breast cancer has been on the rise in Malaysia. It is suggested that a subset of breast cancer cases were associated with germline mutation in breast cancer susceptibility (BRCA) genes. Most of the BRCA mutations reported in Malaysia were point mutations, small deletions and insertions. Here we report the first study of BRCA large genomic rearrangements (LGRs) in Malaysia. We aimed to detect the presence of LGRs in the BRCA genes of Malaysian patients with breast cancer.
Multiplex ligation-dependent probe amplification (MLPA) for BRCA LGRs was carried out on 100 patients (60 were high-risk breast cancer patients previously tested negative/positive for BRCA1 and BRCA2 mutations, and 40 were sporadic breast cancer patients), recruited from three major referral centres, Universiti Kebangsaan Malaysia Medical Centre (UKMMC), Hospital Kuala Lumpur (HKL) and Hospital Putrajaya (HPJ).
Two novel BRCA1 rearrangements were detected in patients with sporadic breast cancer; both results were confirmed by quantitative PCR. No LGRs were found in patients with high-risk breast cancer. The two large genomic rearrangements detected were genomic amplifications of exon 3 and exon 10. No BRCA2 genomic rearrangement was found in both high-risk and sporadic breast cancer patients.
These results will be helpful to understand the mutation spectrum of BRCA1 and BRCA2 genes in Malaysian patients with breast cancer. Further studies involving larger samples are required to establish a genetic screening strategy for both high-risk and sporadic breast cancer patients.
马来西亚的乳腺癌发病率一直在上升。有研究表明,一部分乳腺癌病例与乳腺癌易感基因(BRCA)的种系突变有关。在马来西亚报道的大多数 BRCA 突变是点突变、小的缺失和插入。在此,我们报告了马来西亚首例 BRCA 大片段基因重排(LGR)的研究。我们旨在检测马来西亚乳腺癌患者 BRCA 基因中是否存在 LGR。
对 100 名患者(60 名是先前经 BRCA1 和 BRCA2 突变检测为阴性/阳性的高危乳腺癌患者,40 名是散发性乳腺癌患者)进行了 BRCA LGR 的多重连接依赖性探针扩增(MLPA)检测,这些患者均来自三个主要转诊中心,即马来西亚国民大学医学中心(UKMMC)、吉隆坡医院(HKL)和布城医院(HPJ)。
在散发性乳腺癌患者中检测到了两个新的 BRCA1 重排,均通过定量 PCR 得到了确认。高危乳腺癌患者中未发现 LGR。检测到的两个大片段基因重排分别是外显子 3 和外显子 10 的基因扩增。高危和散发性乳腺癌患者中均未发现 BRCA2 基因重排。
这些结果将有助于了解马来西亚乳腺癌患者中 BRCA1 和 BRCA2 基因的突变谱。需要进一步开展更大样本量的研究,以建立高危和散发性乳腺癌患者的遗传筛查策略。